loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Fluvoxamine

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Fluvoxamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 414Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.

    22 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217917

    FDA
    22 Jan 2024
    Share Share
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.
    Bionpharma's Generic Fluvoxamine Maleate Receives Approval in the U.S.

    22 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217917

    FDA
    22 Jan 2024
    Share Share
    FDA nixes EUA ambitions for Eiger’s COVID treatment
    FDA nixes EUA ambitions for Eiger’s COVID treatment

    06 Oct 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/fda-nixes-eua-ambitions-eigers-covid-treatment-proposes-full-approval-pathway-instead

    Max Bayer FIERCEBIOTECH
    06 Oct 2022
    Share Share
    FDA rejects cheap, generic SSRI as a Covid-19 drug
    FDA rejects cheap, generic SSRI as a Covid-19 drug

    17 May 2022

    // Z. Brennan ENDPTS

    https://endpts.com/unpersuaded-by-the-data-fda-rejects-cheap-generic-ssri-as-a-covid-19-drug/

    Z. Brennan ENDPTS
    17 May 2022
    Share Share
    How a Controversial Off-Patent Psychiatric Treatment Went Legit?
    How a Controversial Off-Patent Psychiatric Treatment Went Legit?

    21 Jan 2022

    // TRIALSITENEWS

    https://trialsitenews.com/fluvoxamines-moment-how-a-controversial-off-patent-psychiatric-treatment-went-legit/

    TRIALSITENEWS
    21 Jan 2022
    Share Share
    University of Minnesota PI Submits EUA Application to FDA for Fluvoxamine
    University of Minnesota PI Submits EUA Application to FDA for Fluvoxamine

    27 Dec 2021

    // TRIALSITENEWS

    https://trialsitenews.com/university-of-minnesota-pi-submits-eua-application-to-fda-for-fluvoxamine/

    TRIALSITENEWS
    27 Dec 2021
    Share Share